Functional Outcomes After Nerve Sparing Surgery for Deep Endometriosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03353935 |
|
Recruitment Status :
Completed
First Posted : November 27, 2017
Last Update Posted : November 27, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Endometriosis | Other: Validated questionnaires |
Surgical tretament for deep endometriosis can produce lesions at the level of the pelvic autonomic system.
Before surgery and 3-12 months after the nerve-sparing surgical procedures, patients were assessed for urinary, sexual and fecal function, in order to evaluate whether sparing of the nerves during the intervention had a beneficial impact on post-operative pelvic function.
| Study Type : | Observational |
| Actual Enrollment : | 36 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Functional Outcomes of Nerve-sparing Laparoscopic Eradication of Deep Infiltrating Endometriosis: a Prospective Analysis Using Validated Questionnaires |
| Actual Study Start Date : | January 2016 |
| Actual Primary Completion Date : | March 2017 |
| Actual Study Completion Date : | March 2017 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
NERVE SPARING
Patients who underwent surgery for deep endometriosis were submitted to surgical procedures aiming at sparing the pelvic ortho- and parasympathetic nerves. The subjects were then followed with interviews using validated questionnaires, to assess the possible changes in post-operative urinary sexual and fecal function.
|
Other: Validated questionnaires
Patients were administered pre- and post-operatively the three validated questionnaires ((FSFI, ICIQ-UI short form Italian, NBD score) investigating sexual, urinary, and fecal function, respectively. |
- Pelvic function [ Time Frame: 6-12 months ]Any change in urinary, sexual or fecal function after surgery, compared to pre-operatively
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Deep endometriosis
- Surgical treatment
- Single surgeon
Exclusion Criteria:
- Lost to follow-up
- unwillingness to answer the interview
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03353935
| Italy | |
| Department of Obstetrics and Gynecology Universita' Dell'Insubria | |
| Varese, Italy, 21100 | |
| Principal Investigator: | Stefano Uccella | Università degli Studi dell'Insubria |
| Responsible Party: | Stefano Uccella, Doctor, Università degli Studi dell'Insubria |
| ClinicalTrials.gov Identifier: | NCT03353935 |
| Other Study ID Numbers: |
630 |
| First Posted: | November 27, 2017 Key Record Dates |
| Last Update Posted: | November 27, 2017 |
| Last Verified: | November 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
surgery pelvic function |
|
Endometriosis |

